Hizentra and Clindamycin hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hizentra and Clindamycin hydrochloride. Common interactions include erythema among females.

The phase IV clinical study analyzes what interactions people who take Hizentra and Clindamycin hydrochloride have. It is created by eHealthMe based on reports of 12 people who take Hizentra and Clindamycin hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On May, 26, 2023

12 people who take Hizentra and Clindamycin hydrochloride together, and have interactions are studied.


What is Hizentra?

Hizentra has active ingredients of human immunoglobulin g. eHealthMe is studying from 19,649 Hizentra users for its effectiveness, alternative drugs and more.

What is Clindamycin hydrochloride?

Clindamycin hydrochloride has active ingredients of clindamycin hydrochloride. It is often used in tooth abscess. eHealthMe is studying from 3,048 Clindamycin hydrochloride users for its effectiveness, alternative drugs and more.

Number of Hizentra and Clindamycin hydrochloride reports submitted per year:

Hizentra and Clindamycin hydrochloride drug interactions.

Common Hizentra and Clindamycin Hydrochloride drug interactions by gender *:

female:

  1. Erythema
  2. Swelling
  3. Epstein-barr virus infection
  4. Fall
  5. Glucose tolerance impaired
  6. Hip arthroplasty
  7. Infusion site rash
  8. Lyme disease
  9. Nausea
  10. Peripheral swelling

male:

n/a

Common Hizentra and Clindamycin Hydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cellulitis
  2. Erythema
  3. Pyrexia
  4. Swelling
  5. Tenderness

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Asthenia
  2. Asthma
  3. Infusion site rash
  4. Lyme disease
  5. Nausea
  6. Peripheral swelling
  7. Weight loss poor
  8. Urinary tract infection
  9. Cardiac disorder
  10. Chest pain

Common conditions people have *:

  1. Immunodeficiency Common Variable: 6 people, 50.00%
  2. Stiff Person Syndrome: 2 people, 16.67%
  3. Local Anaesthesia: 2 people, 16.67%
  4. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 2 people, 16.67%
  5. Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 1 person, 8.33%
  6. Allergic Rhinitis: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Hizentra and Clindamycin hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Hizentra and Clindamycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hizentra side effects:

Browse all side effects of Hizentra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clindamycin hydrochloride side effects:

Browse all side effects of Clindamycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hizentra interactions:

Browse all interactions between Hizentra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clindamycin hydrochloride interactions:

Browse all interactions between Clindamycin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on human immunoglobulin g and clindamycin hydrochloride (the active ingredients of Hizentra and Clindamycin hydrochloride, respectively), and Hizentra and Clindamycin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Hizentra and Clindamycin hydrochloride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: